Aurinia PharmaceuticalsAUPH

那斯達克 · USD
16.35
+0.14
(+0.86%)
盤中 11/07 04:13 (UTC+8)
11/07 04:13 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.57
  • 0.68
  • 0.60
  • 0.62
  • 0.70
  • 0.73
  • 0.77
  • 0.78
  • 0.83
  • 0.84
icon
  • 13.70
  • 18.50
  • -11.66
  • 4.34
  • 12.08
  • 4.94
  • 4.96
  • 0.77
  • 7.10
  • 0.58
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
83,699
83,220
77,705
77,114
73,468
70,008
62,465
59,867
67,771
57,192
營業成本
8,3066,5556,5058,7998,1777,1158,5745,5526,0358,909
營業毛利
75,393
76,665
71,200
68,315
65,291
62,893
53,891
54,315
61,736
48,283
營業費用
40,03030,32429,77835,07635,54642,810-55,98449,98849,796
研發費用
16,61313,0507,47010,8958,4357,4325,7438,1073,0474,080
推銷及管理費用
23,41717,27422,30824,18127,11135,26424,76832,52646,94144,644
非經常性項目費用
-----1141,53315,351-1,072
其他營業費用
----------
營業利益
35,363
46,341
41,422
33,239
29,745
20,083
21,847
-1,669
11,748
-1,513
其他收入及費用
4,2193,3933,5153,4983,3163,1903,5693,9884,2674,189
利息費用
8679481,0121,0471,0991,1171,0671,1461,2081,198
稅前純益
38,715
48,786
43,925
35,690
31,962
22,156
24,349
1,173
14,807
1,478
所得稅
7,01211,3729,570-175,1044116431,005-256457756
稅後純益
31,703
37,414
34,355
210,794
31,551
21,513
23,344
1,429
14,350
722
基本每股稅後盈餘(元)
0.240.290.261.600.240.160.170.010.100.01
稀釋每股稅後盈餘(元)
0.230.280.251.520.230.160.160.010.10-
基本平均股數(千股)
133434.00130081.00132375.00131942.00131808.00134873.00138917.00142179.00143051.00143327.00
稀釋平均股數(千股)
135173.00133530.00137639.00138160.00136008.00137526.00143199.00147675.00145651.00144110.00
還原基本每股稅後盈餘(元)
0.240.290.261.600.240.160.170.010.100.01
還原稀釋每股稅後盈餘(元)
0.230.280.251.520.230.160.160.010.10-
還原基本平均股數(千股)
133,434130,081132,375131,942131,808134,873138,917142,179143,051143,327
還原稀釋平均股數(千股)
135,173133,530137,639138,160136,008137,526143,199147,675145,651144,110
EBITDA(千元)
42,48252,68747,43439,26635,30125,57427,6164,20217,4874,394

大家都在看

HOT